The Centre on Monday revised the clinical guidance for Covid-19 treatment, dropping the off-label use of convalescent plasma from the treatment protocol for adult patients. The development came after a meeting of the ICMR-National Task Force for Covid-19 wherein all members voted in favour of removing the use of convalescent plasma from the guidelines.

Dr Samiran Panda, Indian Council of Medical Research (ICMR) scientist who was also a part of the panel that dropped plasma therapy from Covid-19 management guidelines, told India Today that the decision was taken since anecdotal evidence was very weak, and added that it was not helping patients but only resulting in panic